This week PharmaShots’ news was all about the updates on Clinical Trials, Pharma, Biotech, COVID-19, Regulatory & MedTech. Check out our full report below:

BioCity Biopharma Reports the P-II (2-SUCCEED) Study Data of SC0062 to Treat IgA Nephropathy

Read More: BioCity Biopharma 

HilleVax Provides Update on P-IIb (NEST-IN1) Trial of HIL-214 to Prevent Acute Gastroenteritis (AGE) in Infants

Read More: HilleVax

Antidote Technologies and SEQSTER Join Forces to Improve Patient Identification & Enrollment for Clinical Trials

Read More: Antidote Technologies & SEQSTER

uniQure Reports Data from Two P-I/II Studies of AMT-130 for Treating Huntington’s Disease

Read More: uniQure

Pfizer Reports the Advancement of Danuglipron Development

Read More: Pfizer

Immutep Provides Data from the P-IIb (TACTI-003) Study of Eftilagimod Alfa to Treat Head and Neck Squamous Cell Carcinoma

Read More: Immutep

Hinova Pharmaceuticals’ HP518 Gains the US FDA’s Fast Track Designation to Treat Triple-Negative Breast Cancer (TNBC)

Read More: Hinova Pharmaceutical

Immorna Biotherapeutics Reports the US FDA’s IND Clearance to Commence P-I/II Trial of JCXH-211 IV for Solid Tumors

Read More: Immorna Biotherapeutics

Mirum Pharmaceuticals’ Livmarli Receives the EC’s Approval to Treat Progressive Familial Intrahepatic Cholestasis (PFIC)

Read More: Mirum Pharmaceuticals

Abata Therapeutics Reports the US FDA’s IND Clearance for P-I Trial of ABA-101 for Progressive Multiple Sclerosis

Read More: Abata Therapeutics

Obsidian Therapeutics’ OBX-115 Receives the US FDA’s Fast Track Designation to Treat Advanced Melanoma

Read More: Obsidian Therapeutics

The NMPA Grants Breakthrough Therapy Designation to AusperBio’s AHB-137 for Treating Chronic Hepatitis B

Read More: AusperBio

Biophytis Reports the US FDA’s IND Clearance to Initiate the P-II Trial of BIO101 for Treating Obesity

Read More: Biophytis 

AskBio’s (Bayer's Subsidiary) AB-1005 Gains the US FDA’s Fast Track and MHRA’s Innovation Passport Designations for Parkinson’s Disease

Read More: Bayer

AstraZeneca’s Tagrisso Plus Chemotherapy Receives Health Canada’s Approval to Treat Advanced Lung Cancer

Read More: AstraZeneca

Roche’s Accu-Chek SmartGuide CGM System Gains CE Mark for Diabetic Patients

Read More: Roche

Orthofix Medical Reports the US FDA’s Clearance of Fitbone Transport and Lengthening System

Read More: Orthofix Medical

Eli Lilly to Acquire Morphic Holdings for an Aggregate of ~$3.2B

Read More: Eli Lilly & Morphic Holdings

TuHURA Biosciences to Acquire Kineta’s KVA12123 for Treating Solid Tumors

Read More: TuHURA & Kineta

Ligand Pharmaceuticals Reports the Acquisition of APEIRON Biologics for $100M

Read More: Ligand Pharmaceuticals & APEIRON Biologics

Illumina Reports the Acquisition of Fluent BioSciences to Expand its Multiomics Portfolio

Read More: Illumina

Certara to Expand its Drug Discovery Software Capabilities Through the Acquisition of Chemaxon

Read More: Certara & Chemaxon

Evotec Partners with Pfizer for Drug Discovery Advancement Across France

Read More: Evotech & Pfizer

XyloCor Therapeutics Partners with SmartCella for its Technology to Deliver XC001 as a Treatment of Refractory Angina

Read More: XyloCor Therapeutics & SmartCella

Ipsen Teams Up with Foreseen Biotechnology to Develop FS001 for Solid Tumors

Read More: Ipsen & Biotechnology

Abeona Therapeutics Collaborates with Beacon Therapeutics to Develop AAV204 Capsid for Certain Ophthalmology Indications

Read More: Abeona Therapeutics & Beacon Therapeutics

AB Science Provides Update on P-II Trial Design of Masitinib for COVID-19

Read More: AB Science

The US FDA Grants Clearance to ImmersiveTouch’s Augmented Reality Surgical System

Read More: ImmersiveTouch

MEKanistic Therapeutics Reports Preclinical Results of MTX-531 for Cancer Treatment

Read More: MEKanistic Therapeutics

Sirnaomics Completes the Preclinical Study of STP125G for Treating Cardiovascular Diseases

Read More: Sirnaomics

Related Post: PharmaShots Weekly Snapshots (July 01 – July 05, 2024)